Scholar Rock (SRRK.US) — market event timeline

nashnova tracks 1 market event mentioning Scholar Rock (SRRK.US) as of 2026-09-30, each with a dated one-line analysis of how the event relates to the asset.

1. 2026-09-30Regeneron's Combination with Novo Nordisk's Semaglutide Cuts Muscle Loss by Half

   A pure-play focused on the myostatin pathway, directly competing with trevogrumab in the same space. Regeneron's data validates the feasibility of this target.

For research and information only — not investment advice.